The present invention relates to compounds of formula (I) and its analogues (II) and (III): in which R1-R14, X, Y, Z1-Z4 are in the Summary of the Invention; capable of inhibiting the activity of RBD of SARS-COV-2 in its “closed” conformation before it binds with the human ACE2 receptor. The invention further provides a process for the preparation of compounds of the invention.
本发明涉及式(I)及其类似物(II)和(III)的化合物:其中R1-R14,X,Y,Z1-Z4在本发明摘要中;能够抑制
SARS-COV-2的RBD在其“闭合”构象中与人类ACE2受体结合之前的活性。本发明还提供了本发明化合物的制备方法。